Kenvue's interim CEO Kirk Perry met Robert F. Kennedy Jr. to try and dissuade him from listing Tylenol as a potential cause ...

Despite Kenvue’s recent underperformance relative to the Dow, analysts remain moderately optimistic about the stock’s ...

Tylenol-maker Kenvue Inc. spoke with Health Secretary Robert F. Kennedy Jr. in a bid to keep the over-the-counter painkiller ...

Kenvue interim CEO Kirk Perry met privately this week with RFK Jr. to argue that there is no proven link between Tylenol and ...

Citi lowered the firm’s price target on Kenvue (KVUE) to $20 from $22 and keeps a Neutral rating on the shares. The firm updated models in the beverages and home and personal care group. Citi favors ...

Kenvue rushed to the defense of Tylenol, but the stock still suffered a record selloff on news that RFK Jr. will release a ...

Beyond oral care, Kenvue is aligning its strategy with the government’s Healthy China 2030 initiative, a national plan to ...

Kenvue (KVUE) stock is in focus as the company prepares a strong defense as an HHS report may link its Tylenol (acetaminophen ...

If you have been watching Kenvue (KVUE) lately, there is a good chance the news has caught your attention. A series of ...

Kenvue just opened its global headquarters right here in New Jersey. Who is Kenvue? Do they make Tylenol? What to know about ...

Shares of Kenvue fell more than 10% on Friday after a report that Health Secretary Robert F. Kennedy Jr. will likely link ...

Kenvue Inc.’s shares fell after the Wall Street Journal reported that Health and Human Services Secretary Robert F. Kennedy ...